Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of TdaP versus Td booster vaccination in adults
2009-013411-36Phase 3Completed
- Sponsor
- Statens Serum Institut
- Start
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of tetanus toxoid + diphtheria toxoid + acellular pertussis in pertussis (2 arms), sponsored by Statens Serum Institut. Primary endpoint: Anti-pertussis toxin antibody concentrations. Started Nov 2009; status: completed.
02
Drugs
tetanus toxoid + diphtheria toxoid + acellular pertussis
03
Conditions
pertussis
Beyond the preview
Go deeper on 2009-013411-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013411-36.